NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| hemorrhoidal maximum strength pain relief | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Kroger Company | 3c8f90e2-fecf-4439-9faa-81a32ffe4753 | 2024-09-26 | Warnings | 4T6H12BN9U |
| DG Health Antibiotic | NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | Dolgencorp Inc | efaf3ea5-0a2f-414f-96eb-7e8cfba9e901 | 2024-09-26 | Warnings | M004 |
| Good Sense First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | A-S Medication Solutions | 29c223ff-3cb7-4578-a326-08516e89cd47 | 2024-09-26 | Warnings | M004 89Y4M234ES |
| equate hemorrhoidal | GLYCERIN, PHENYLEPHRINE HCL, PRAMOXINE HCL, WHITE PETROLATUM | Wal-Mart Stores Inc | 5ccefdbd-bbbe-4cbf-9fdb-3c568643e14d | 2024-09-26 | Warnings | 4T6H12BN9U |
| Signature Care First Aid Antibiotic | NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | Safeway | 78ecfb28-f4c4-4f70-90c9-d6d7bf920fb5 | 2024-09-26 | Warnings | M004 |
| Good Neighbor Pharmacy Antibiotic and Pain Relief | NEOMYCIN, POLYMYXIN B, PRAMOXINE HCL | Amerisource Bergen | 3d1694ea-3f3e-45d5-8edf-8b31ac7d3a40 | 2024-09-26 | Warnings | M004 |
| Soothe Night Time | WHITE PETROLATUM MINERAL OIL | Bausch & Lomb Incorporated | 638d3c3f-9960-43da-956e-0e28c77f533e | 2024-09-24 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Rexall Antibiotic | BACITRACIN | Dolgencorp, LLC | 7ad42602-6e42-47c8-91a8-e4785fa8d24b | 2024-09-23 | Warnings | M004 |
| bacitracin | BACITRACIN | H E B | 0a5eeef0-309b-4edd-a664-3d9c1c74a6e9 | 2024-09-23 | Warnings | M004 |
| DABUR Vitamin A and D | WHITE PETROLATUM | Dabur India Limited | 22cd44ef-4b02-604d-e063-6394a90a7a0a | 2024-09-23 | Warnings | 4T6H12BN9U |
| signature care first aid antibiotic | BACITRACIN | Safeway | 38fc0c5c-e0bc-44d2-acbd-d4d329fef1e1 | 2024-09-23 | Warnings | M004 |
| Antibiotic | BACITRACIN | Topco Associates LLC | 3267a695-9e53-42f2-b30a-022653a0b8bb | 2024-09-23 | Warnings | M004 |
| Bacitracin | BACITRACIN | Kroger Company | 4490cece-0635-4ea7-91ab-324a971fef63 | 2024-09-23 | Warnings | M004 |
| triple antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Padagis Israel Pharmaceuticals Ltd | 28fff253-ddd4-4669-aa90-b4caf48c905f | 2024-09-22 | Warnings | M004 89Y4M234ES |
| Walgreens Hemorrhoidal Pain Relief | GLYCERIN 14.4%, LIDOCAINE 5%, PETROLATUM 15%, PHENYLEPHRINE HCL 0.25% | Walgreens | e79ed7ae-0d06-2f88-e053-2995a90a1e35 | 2024-09-20 | Warnings | 4T6H12BN9U |
| Soothe XP Preservative Free | LIGHT MINERAL OIL AND MINERAL OIL | Bausch & Lomb Incorporated | b254d885-6d49-4c95-b6be-cfdad49c85e6 | 2024-09-20 | Warnings | T5L8T28FGP |
| Soothe XP | LIGHT MINERAL OIL AND MINERAL OIL | Bausch & Lomb Incorporated | c0f053da-8d22-433e-a36e-79cf15ad387f | 2024-09-20 | Warnings | T5L8T28FGP |
| Signature Care Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Safeway | 044aff98-f398-40f5-8c18-2751b4ab4384 | 2024-09-18 | Warnings | M004 89Y4M234ES |
| careone triple antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | American Sales Company | 09a0b0b9-1806-4ff9-80fa-448dabbf2cc7 | 2024-09-18 | Warnings | M004 89Y4M234ES |
| equaline first aid antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | United Natural Foods, Inc. dba UNFI | 022e009e-0192-4089-86f3-4d63448e0f88 | 2024-09-18 | Warnings | M004 89Y4M234ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.